Nebivolol Atb

Nebivolol, the active ingredient in Nebivolol Atb, is a beta blocker presented as an oral tablet for oral use. It is indicated for the management of hypertension in adult patients. GNH USA supplies Nebivolol Atb as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic blocker used in the treatment of cardiovascular conditions related to elevated blood pressure.

- Hypertension: lowers elevated blood pressure and reduces cardiovascular risk in adults.

Nebivolol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache reported during initial therapy. - Dizziness: transient light‑headedness, especially when standing quickly. - Fatigue: general tiredness or reduced energy levels. - Nausea: occasional upset stomach or feeling of queasiness. - Bradycardia: slower than normal heart rate. - Peripheral edema: mild swelling of the ankles or feet.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Hypotension: significant drop in blood pressure causing faintness. - Heart block: impairment of electrical conduction in the heart. - Bronchospasm: narrowing of airways, particularly in patients with reactive airway disease. - Allergic reactions: rash, itching, or swelling of the face and throat. - Cardiogenic shock: rare but life‑threatening cardiac failure.

When prescribing or dispensing Nebivolol, consider the following safety measures.

- Monitor blood pressure: ensure adequate control without excessive lowering. - Assess heart rate: watch for bradycardia, especially in patients with pre‑existing conduction disorders. - Use caution in asthma or COPD: β‑blockade may exacerbate bronchospasm. - Avoid abrupt discontinuation: tapering reduces risk of rebound hypertension. - Adjust dose in renal impairment: renal function may affect drug clearance. - Store at ambient temperature: keep in the original pack, protect from moisture.

Nebivolol can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Other beta‑blockers: additive bradycardia and hypotension. - Strong CYP2D6 inhibitors (e.g., paroxetine, quinidine): increased nebivolol plasma concentrations. - Calcium channel blockers that affect AV node (verapamil, diltiazem): risk of severe bradycardia.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring. - Insulin or oral hypoglycemics: nebivolol may mask hypoglycemia symptoms. - NSAIDs: can reduce the antihypertensive efficacy of nebivolol.